Yasuo Sawada
About
In The Last Decade
Yasuo Sawada
25 papers receiving 357 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 137
- Plant Science 120
- Gastroenterology 92
- Surgery 83
- Biotechnology 62
Countries citing papers authored by Yasuo Sawada
This map shows the geographic impact of Yasuo Sawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Sawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Sawada more than expected).
Fields of papers citing papers by Yasuo Sawada
This network shows the impact of papers produced by Yasuo Sawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Sawada. The network helps show where Yasuo Sawada may publish in the future.
Co-authorship network of co-authors of Yasuo Sawada
This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Sawada. A scholar is included among the top collaborators of Yasuo Sawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Sawada. Yasuo Sawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 94 | |
| 2 | 5 | |
| 3 | 88 | |
| 4 | 40 | |
| 5 | Soil Microbial Biomass in a Sasa-type (Pleioblastus) grassland | 5 |
| 6 | 18 | |
| 7 | 15 | |
| 8 | [Cefotiam concentration in exudate from suction drain of patients with breast cancer following intravenous administration]. | 1 |
| 9 | Pharmacokinetics of cefotiam in the exudate from wounds of patients with breast cancer operated upon for radical mastectomy. | 2 |
| 10 | 7 | |
| 11 | Clinical studies on hapa-b following intramuscular administration on biliary tract infection and acute peritonitis (tissue concentration and clinical efficacy) | 2 |
| 12 | [The causes of abnormal coagulation system in the early phase of burns]. | 1 |
| 13 | Cefpiramide (SM-1652) concentration in infected tissues from patients following intravenous administration | 1 |
| 14 | [Clinical studies on amikacin for infectious diseases following intravenous drip infusion (author's transl)]. | 2 |
| 15 | [Studies on cefotaxime (HR 756) concentration in human biliary tract and clinical effect for acute or subacute cholecystitis with cholelithiasis (author's transl)]. | 1 |
| 16 | 21 | |
| 17 | 31 | |
| 18 | DIBEKACIN CONCENTRATION IN VARIOUS TISSUES OF PATIENTS | 2 |
| 19 | Doxycycline concentrations in certain tissues of man following intravenous administration | 2 |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.